BB BIOTECH AG

Q1 2016 13F Holdings Report, Stock Holdings

Signature - Title
Martin Gubler / Ivo Betschart - SIGNING AUTHORITY
Location
Schaffhausen, Switzerland
Holdings as of
March 31, 2016
Value $
$2.52B
Num holdings
29
Date filed
5/12/2016, 05:12 PM
Description
All US holdings of this investor are reported in this report. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q4 2015 - Feb 9, 2016
Next filing
Q2 2016 - Aug 12, 2016
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2016 Q1 compared to 2015 Q4 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Ivo Betschart SIGNING AUTHORITY Schaffhausen, Switzerland 5/11/2016

Bellevue Group AG is reporting for BB BIOTECH AG:

Name Holdings Value Location File Number
Bellevue Group AG $6.17B Kuesnacht, Switzerland 028-17462

Other Included Managers (4):

Num Name Location File Number
1 Biotech Focus N.V. 028-11193
2 Biotech Invest N.V. 028-11191
3 Biotech Target N.V. 028-11189
4 Biotech Growth N.V. 028-11194